BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 11313442)

  • 1. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
    Huang CC; Lo SW; Hsu KS
    J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
    Gerdeman G; Lovinger DM
    J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord.
    Morisset V; Urban L
    J Neurophysiol; 2001 Jul; 86(1):40-8. PubMed ID: 11431486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens.
    Robbe D; Alonso G; Duchamp F; Bockaert J; Manzoni OJ
    J Neurosci; 2001 Jan; 21(1):109-16. PubMed ID: 11150326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells.
    Takahashi KA; Linden DJ
    J Neurophysiol; 2000 Mar; 83(3):1167-80. PubMed ID: 10712447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
    Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
    J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
    Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
    Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids.
    Hoffman AF; Lupica CR
    J Neurophysiol; 2001 Jan; 85(1):72-83. PubMed ID: 11152707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
    Hájos N; Ledent C; Freund TF
    Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus.
    Hoffman AF; Lupica CR
    J Neurosci; 2000 Apr; 20(7):2470-9. PubMed ID: 10729327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.
    Hoffman AF; Laaris N; Kawamura M; Masino SA; Lupica CR
    J Neurosci; 2010 Jan; 30(2):545-55. PubMed ID: 20071517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures.
    Kim DJ; Thayer SA
    Brain Res; 2000 Jan; 852(2):398-405. PubMed ID: 10678767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
    Szabo B; Siemes S; Wallmichrath I
    Eur J Neurosci; 2002 Jun; 15(12):2057-61. PubMed ID: 12099913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid 1 and transient receptor potential vanilloid 1 receptors discretely modulate evoked glutamate separately from spontaneous glutamate transmission.
    Fawley JA; Hofmann ME; Andresen MC
    J Neurosci; 2014 Jun; 34(24):8324-32. PubMed ID: 24920635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2.
    Németh B; Ledent C; Freund TF; Hájos N
    Neuropharmacology; 2008 Jan; 54(1):51-7. PubMed ID: 17714744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
    Ameri A; Wilhelm A; Simmet T
    Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPA receptor-mediated presynaptic inhibition at cerebellar GABAergic synapses: a characterization of molecular mechanisms.
    Satake S; Saitow F; Rusakov D; Konishi S
    Eur J Neurosci; 2004 May; 19(9):2464-74. PubMed ID: 15128400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids.
    Diana MA; Levenes C; Mackie K; Marty A
    J Neurosci; 2002 Jan; 22(1):200-8. PubMed ID: 11756503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study.
    Pistis M; Muntoni AL; Pillolla G; Gessa GL
    Eur J Neurosci; 2002 Jun; 15(11):1795-802. PubMed ID: 12081659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus.
    Hoffman AF; Riegel AC; Lupica CR
    Eur J Neurosci; 2003 Aug; 18(3):524-34. PubMed ID: 12911748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.